Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2020-04-29 | Dr. Cobuzzi has served as a director since January 2020. The Board believes Dr. Cobuzzi’s experience and insight with drug development and business development and funding provide him with the qualifications to serve as a director. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-25